Luminol Crystalline Form II Production via Open-Air Evaporation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Commercially available luminol powders suffer from mediocre crystallinity, which is problematic for pharmaceutical applications requiring pure and stable forms, especially in topical dosage forms and bioanalytical methods where reproducibility and long-term stability are critical.

Innovation Solution

A new crystalline form of luminol (Form II) is produced using a simpler method involving a stirred solution of Na-luminolate in demineralized water, with hydrochloric acid addition, filtration, washing, and drying, which yields phase-pure crystals with improved crystallinity and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If controlled sublimation at 180°C and 5 Torr vacuum pressure is used to produce crystalline luminol, then phase-pure crystals are obtained, but the production method becomes cumbersome and time-consuming (several weeks)

Engineering Contradiction:
ImprovecrystallinityVSAvoidproduction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The patent changes the crystallization parameters from controlled sublimation (180°C, 5 Torr vacuum) to simple evaporation in open air at room temperature or slightly elevated temperatures, completely transforming the process conditions while achieving the desired crystalline form

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the complex vacuum sublimation system with a simple open-air evaporation process, eliminating the need for vacuum equipment and temperature control apparatus while achieving comparable or superior crystallization results

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If controlled sublimation is used to grow luminol crystals, then pure crystalline form is achieved, but complex equipment and closed environment are required

Engineering Contradiction:
ImprovecrystallinityVSAvoidequipment complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces the complex vacuum sublimation system with a simple open-air evaporation process, eliminating the need for vacuum equipment and temperature control apparatus while achieving comparable or superior crystallization results

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent allows the crystallization process to proceed naturally in open air using ambient conditions, with the solvent evaporating on its own and crystals forming spontaneously without requiring controlled environment equipment

Inventive Principle:
Principle #25Self-service

3Ease of manufacture

If commercially available luminol powders are used, then production is simple, but crystallinity is mediocre with broad overlapping reflections in PXRD patterns

Engineering Contradiction:
ImproveavailabilityVSAvoidcrystallinity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent performs preliminary crystallization by allowing the solvent to evaporate completely before use, transforming the amorphous commercial powder into a well-defined crystalline form that exhibits sharp PXRD reflections and improved stability

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new crystalline form of luminol (Form II) offers higher reproducibility, reduced production time, and lower costs due to less complex equipment requirements, making it suitable for pharmaceutical and bioanalytical applications where purity and stability are essential.

Implementation Method 1

A stirred solution of Na-luminolate in demineralized water, with hydrochloric acid addition, filtration, washing, and drying, which yields phase-pure crystals

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Implementation Method 2

Adding hydrochloric acid (10 to 38%) to said solution in a temperature range of 5 to 50° C. over a period of 1 sec to 60 min

Methodology Applied
Scientific EffectAcid-base neutralization: Chemical Bonding

Implementation Method 3

A new crystalline form of luminol (Form II) is produced using a simpler method involving a stirred solution of Na-luminolate in demineralized water

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 4

drying the precipitate at room temperature for 6 to 48 h

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS11111218B2Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione
Publication Date: 2021.09.07 METRIOPHARM AG
  • US11111218B2 patent drawing
  • US11111218B2 patent drawing
  • US11111218B2 patent drawing

AI summary

A new crystalline form of 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) is provided. Advantageous uses for this crystalline form as a detecting agent or as an agent for forensic purposes are disclosed, as well a pharmaceutical composition containing said crystalline form.